These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 15872368

  • 1. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M, Luster M, Hänscheid H, Reiners C.
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 131I dosimetry and thyroid stunning.
    Gerard SK, Park HM.
    J Nucl Med; 2003 Dec; 44(12):2039-40; author reply 2040. PubMed ID: 14660731
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M, Hänscheid H, Reiners C, Thomas SR.
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract] [Full Text] [Related]

  • 7. Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinoma.
    Hänscheid H, Lassmann M, Luster M, Kloos RT, Reiners C.
    Endocr Relat Cancer; 2009 Dec; 16(4):1283-9. PubMed ID: 19628649
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma.
    Fard-Esfahani A, Mirshekarpour H, Fallahi B, Eftekhari M, Saghari M, Beiki D, Ansari-Gilani K, Takavar A.
    Clin Nucl Med; 2007 Sep; 32(9):696-9. PubMed ID: 17710021
    [Abstract] [Full Text] [Related]

  • 14. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.
    Hänscheid H, Lassmann M, Luster M, Thomas SR, Pacini F, Ceccarelli C, Ladenson PW, Wahl RL, Schlumberger M, Ricard M, Driedger A, Kloos RT, Sherman SI, Haugen BR, Carriere V, Corone C, Reiners C.
    J Nucl Med; 2006 Apr; 47(4):648-54. PubMed ID: 16595499
    [Abstract] [Full Text] [Related]

  • 15. Radioiodine therapy of thyroid autonomy.
    Reiners C, Schneider P.
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [Abstract] [Full Text] [Related]

  • 16. Detection of short-term chromosomal damage due to therapeutic 131I exposure in patients with thyroid cancer.
    Hernández-Jardines A, Molina B, del Castillo V, Papadakis M, Rivera T, Azorín J, Herrera LA, Yokoyama E, Frías S.
    Rev Invest Clin; 2010 Aug; 62(1):31-8. PubMed ID: 20415057
    [Abstract] [Full Text] [Related]

  • 17. Patient parameters and other radiation safety issues in 131I therapy for thyroid cancer treatment.
    Al-Haj AN, Lagarde CS, Lobriguito AM.
    Health Phys; 2007 Dec; 93(6):656-66. PubMed ID: 17993846
    [Abstract] [Full Text] [Related]

  • 18. The sodium-iodine symporter and the proton-pump inhibitors in - related to the side effects of- the treatment of thyroid cancer with iodine-131.
    Sfakianakis G, Sfakianaki E.
    Hell J Nucl Med; 2007 Dec; 10(1):2-5. PubMed ID: 17450241
    [Abstract] [Full Text] [Related]

  • 19. Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
    Tuttle RM, Leboeuf R, Robbins RJ, Qualey R, Pentlow K, Larson SM, Chan CY.
    J Nucl Med; 2006 Oct; 47(10):1587-91. PubMed ID: 17015892
    [Abstract] [Full Text] [Related]

  • 20. The continuous debate in literature about the usage of iodine-131 dosing for the ablation of thyroid remnants and metastases.
    De Klerk JM, Oyen WJ.
    Minerva Endocrinol; 2009 Mar; 34(1):57-69. PubMed ID: 19209128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.